Often called the guardian of the genome or the master tumor suppressor gene, p53 has long been known to keep tumors at bay. Now, recent research shows that three microRNAs help p53 out, especially in preventing lung cancer. Previous studies focused mainly on the coding genes that p53 regulates, but recently, researchers have begun to take an interest in non-coding genes’ roles in tumor development as well, says Guido Bommer, a postdoctoral fellow in Eric Fearon’s lab at the University of Michigan.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.